Related Experiment Video
Updated: Jul 5, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
[Vulvovaginal candidiasis in girls (guidelines for a practitioner)]
Insights
Recurrent vaginal candidiasis in girls is a significant issue, often stemming from improper antifungal drug prescription and ineffective treatments. This study highlights effective drugs for restoring vaginal microbiocenosis in pediatric cases.
Area of Science:
- Medical Mycology
- Gynecology
- Pediatrics
Context:
- High frequency of relapses in vaginal candidiasis cases.
- Increasing incidence of pediatric candidiasis.
- Inappropriate prescription of antifungal drugs by pediatricians, including the use of nystatin, which is ineffective for vaginal candidiasis.
Purpose:
- To present specific characteristics of vulvovaginal candidiasis origin and development in girls.
- To identify and recommend drugs with proven efficacy for normalizing vaginal microbiocenosis in pediatric patients.
Summary:
- The study addresses the challenges in treating vaginal candidiasis, particularly recurrent and pediatric cases.
- It criticizes the common practice of prescribing ineffective antifungal treatments like nystatin and highlights issues with generic drug quality.
- The paper details the specific factors contributing to vulvovaginal candidiasis in girls and proposes effective therapeutic agents.
Impact:
- Provides guidance for pediatricians on appropriate antifungal therapy for girls.
- Aims to reduce the recurrence rates of vaginal candidiasis in pediatric populations.
- Contributes to improving the management of vaginal candidiasis by recommending evidence-based treatments.
Abstract:
There are many publications on the problems of the vaginal candidiasis treatment. Still, the actuality is in the frequency of the relapses and registration of the pediatric cases. Unfortunately, the majority of the pediatrists prescribe antibiotics but either forget to prescribe the simultaneous use of antifungal drugs, or prescribe nystatin, an antimycotic, that is known to be active only in the intestine lumen. As a result, candidiasis of the stomatopharynx or vagina is developed. Of no less importance is the fact of marketing many generics in Russia, which often prove to be false after their detailed investigation. The paper presents specific characteristics pertaining to the origin and development of vulvovaginal candidiasis in girls and indicates drugs with proved efficacy in normalization of the vagina microbiocenosis in girls.
Related Concept Videos
Candidiasis
Trichomoniasis
Genital Herpes
Disorders of the Female Reproductive System
Cryptococcal Meningitis
Urinary Tract Infection IV: Nursing Management

